Patent ID: 11918612
Assignee: SERES THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 0:
1. A composition comprising: (a) a first species of an isolated bacterium capable of forming a spore, (b) a second species of isolated bacterium capable of forming a spore, (c) a third species of isolated bacterium capable of forming a spore, and (d) a capsule;
wherein the capsule encapsulates the first species, the second species, and the third species;
wherein the first species, the second species, and the third species of bacteria are not identical;
wherein the first species is Clostridium orbiscindens, the second species is Clostridium bolteae, and the third species is Lachnospiraceae bacterium 5_1_57FAA, wherein the Clostridium orbiscindens comprises a 16S rDNA sequence that is at least 97% identical to the sequence set forth in SEQ ID NO: 609;
and wherein a combination of the first species, the second species, and the third species is capable of decreasing and/or inhibiting the growth and/or colonization of at least one type of pathogenic bacteria.